CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The COMbAT project aims to develop a personalized therapy tool for melanoma patients by targeting specific driver mutations in their cancer genomes. Using innovative preclinical models, the project seeks to enhance treatment efficacy and reduce the burden of unnecessary chemotherapy.
Melanoma tumours develop in the pigment cells located in the skin.
It is the most aggressive and treatment-resistant type of skin cancer as well as the leading cause of death among skin diseases.
Moreover, melanoma’s alarming increase in incidence, especially in the young population, in combination with its propensity for lethal metastasis, illustrates an urgent need for new treatment strategies.
In this PoC project, we propose developing an innovative tool, called COMbAT, for designing highly p…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
